Survival after the Onset of De Novo Donor Specific Anti-HLA Antibodies in a Consecutive Series of "Low-Risk" Renal Transplant Patients

被引：0
|
作者：
Everly, M. J. [1 ,2 ]
Rebellato, L. M. [3 ]
Ozawa, M. [1 ,2 ]
Briley, K. P. [3 ]
Catrou, P. G. [3 ]
Bolin, P. [3 ]
Kendrick, W. T. [4 ]
Kendrick, S. A. [4 ]
Haisch, C. E. [3 ]
Harland, R. C. [3 ]
Terasaki, P. I. [1 ]
机构：
[1] Terasaki Fdn, Los Angeles, CA USA
[2] One Lambda Inc, Los Angeles, CA USA
[3] E Carolina Univ, Brody Sch Med, Greenville, NC USA
[4] Eastern Nephrol & Associates, Greenville, NC USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2012年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
180
引用
收藏
页码：80 / 80
页数：1
相关论文
共 50 条
  • [21] Flow-PRA characterisarion of de novo Anti-HLA class I donor specific antibodies in patients with apparent 'transplant accommodation'.
    Dorling, Anthony
    Hingley, Sakura
    Clarke, Helen M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 345 - 345
  • [22] Importance and What to Watch Out for De Novo Donor Specific Anti-HLA Antibodies after Kidney Transplantation
    Yang, Chul Woo
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2018, 33 (34)
  • [23] CHARACTERISTICS OF DONOR-SPECIFIC ANTI-HLA ANTIBODIES IN RENAL TRANSPLANT RECIPIENTS.
    Ghandorah, Salim
    Yilmaz, Serdar
    Abadi, Abdulnaser
    Rahmanian, Taleb
    Wang, Jinguo
    Khan, Faisal M.
    Berka, Noureddine
    HUMAN IMMUNOLOGY, 2015, 76 : 163 - 163
  • [24] Non-Complement-Binding De Novo Donor-Specific Anti-HLA Antibodies and Kidney Allograft Survival
    Guidicelli, Gwendaline
    Guerville, Florent
    Lepreux, Sebastien
    Wiebe, Chris
    Thaunat, Olivier
    Dubois, Valerie
    Visentin, Jonathan
    Bachelet, Thomas
    Morelon, Emmanuel
    Nickerson, Peter
    Merville, Pierre
    Taupin, Jean-Luc
    Couzi, Lionel
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 27 (02): : 615 - 625
  • [25] DE NOVO DONOR-SPECIFIC HLA ANTIBODIES IN LOW RISK PEDIATRIC KIDNEY TRANSPLANT RECIPIENTS
    Yilmaz, Alev
    Oguz, Fatma Savran
    Usta, Sebahat
    Yildirim, Zeynep Yuruk
    Pehlivanoglu, Cemile
    Kekik, Cigdem
    Emre, Sevinc
    PEDIATRIC NEPHROLOGY, 2015, 30 (09) : 1724 - 1724
  • [26] DE NOVO DONOR-SPECIFIC HLA ANTIBODIES IN LOW RISK PEDIATRIC KIDNEY TRANSPLANT RECIPIENTS
    Yilmaz, A.
    Yildirim, Z. Yuruk
    Pehlivanoglu, C.
    Nayir, A.
    Emre, S.
    Savran, F. Oguz
    Usta, S.
    Kekik, C.
    PEDIATRIC TRANSPLANTATION, 2015, 19 : 125 - 125
  • [27] Prospective Monitoring of Donor-specific Anti-HLA Antibodies After Intestine/Multivisceral Transplantation: Significance of De Novo Antibodies
    Kubal, Chandrashekhar
    Mangus, Richard
    Saxena, Romil
    Lobashevsky, Andrew
    Higgins, Nancy
    Fridell, Jonathan
    Tector, A. Joseph
    TRANSPLANTATION, 2015, 99 (08) : E49 - E56
  • [28] De Novo Donor-Specific Anti-HLA Antibodies Are a Risk Factor for the Development of Biliary Strictures After DBD Liver Transplantation
    Foley, D.
    Ellis, T.
    D'Alessandro, A.
    Powell, A.
    Leverson, G.
    Musat, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 177 - 177
  • [29] De Novo Donor-Specific Anti-HLA Antibodies Are a Risk Factor for the Development of Biliary Strictures After DBD Liver Transplantation
    Foley, D.
    Ellis, T.
    D'Alessandro, A.
    Powell, A.
    Leverson, G.
    Musat, A.
    TRANSPLANTATION, 2014, 98 : 177 - 177
  • [30] Late Antibody-Mediated Rejection Due To De-Novo Donor-Specific Anti-HLA Antibodies in Heart Transplant Recipients: A Cohort of 20 Consecutive Patients
    Coutance, G.
    Ouldamar, S.
    Rouvier, P.
    Suberbielle, C.
    Saheb, S.
    Hariri, S.
    Brechot, N.
    Lebreton, G.
    Leprince, P.
    Varnous, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (04): : S178 - S178
12345